Modulation of CD200 receptors as a novel method of immunosuppression

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.5, 2003-05, pp. : 711-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 239-250

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric Modulation of Dopamine Receptors

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 6, 2005-06 ,pp. : 555-561

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site

Current Drug Targets, Vol. 12, Iss. 11, 2011-10 ,pp. : 1674-1688

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Kv1.3 blockers for immunosuppression: WO2012155199

By Nguyen William

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1511-1516

Informa Healthcare

Access to resources Recommend Favorite

Allosteric modulation of muscarinic acetylcholine receptors

By Tucek S. Proska J.

Trends in Pharmacological Sciences, Vol. 16, Iss. 6, 1995-06 ,pp. : 205-212

Elsevier

Access to resources Recommend Favorite